Skip to main content
Valiant Laboratories Limited logo

Valiant Laboratories Limited — Investor Relations & Filings

Ticker · VALIANTLAB ISIN · INE0JWS01017 LEI · 335800VKNJKWJ4LD6855 BSE.NS Manufacturing
Filings indexed 171 across all filing types
Latest filing 2025-07-05 Regulatory Filings
Country IN India
Listing BSE.NS VALIANTLAB

About Valiant Laboratories Limited

https://www.valiantlabs.in/

Valiant Laboratories Limited specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs) and bulk drugs, with a primary focus on the production of Paracetamol. The company operates dedicated manufacturing facilities designed for the large-scale synthesis of analgesic and antipyretic compounds. By maintaining rigorous quality control standards and process efficiencies, it serves as a key supplier for formulations across various therapeutic segments. Its core business activities encompass the chemical processing and distribution of high-grade medicinal ingredients, catering to a diverse range of healthcare manufacturers. The organization prioritizes technical excellence in API synthesis and the optimization of production workflows to ensure a consistent supply of essential pharmaceutical components.

Recent filings

Filing Released Lang Actions
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-07-05 English
Board Meeting — Fund Raising
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about a scheduled Board Meeting to consider proposals for raising funds through various methods such as public offers, rights issues, and other securities issuance. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures about board meetings and related decisions. The document does not contain actual financial data or results but is an announcement of an upcoming board meeting focused on capital raising activities. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is short and it is not a report or financial statement itself, but an update about financing plans.
2025-07-05 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges and compliance departments, informing about the closure of the 'Trading Window' for insiders ahead of the financial results announcement for the quarter ending June 30, 2025. It references SEBI regulations on insider trading and the company's code of conduct. The document does not contain any financial data, results, or detailed report content but is an announcement related to trading restrictions due to upcoming financial disclosures. This type of communication is a regulatory announcement related to compliance and insider trading rules, not a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS). The document length is short (2236 characters), and it is an announcement rather than a report itself.
2025-06-27 English
Credit Rating
Regulatory Filings Classification · 95% confidence The document is a notification addressed to stock exchanges regarding a credit rating assigned to the company's banking facilities. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations for listed companies. The content is an update on credit rating, not a financial report, earnings release, or management discussion. It is a regulatory announcement about credit rating changes, which fits best under Regulatory Filings (RNS) as it does not fit other specific categories like Capital/Financing Update or Interest Rate Update. The document is short and informational, not a report or presentation.
2025-06-26 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2025-06-25 English
Outcome of Board Meeting
Regulatory Filings
2025-05-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.